Berberis composition for cognitive health
US-2024424045-A1 · Dec 26, 2024 · US
US9642389B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9642389-B2 |
| Application number | US-201013145101-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 29, 2010 |
| Priority date | Jan 29, 2009 |
| Publication date | May 9, 2017 |
| Grant date | May 9, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a composition comprising oil palm phenolics for use in providing neuroprotective effects and improving cognitive and motor functions abilities.
Opening claim text (preview).
The invention claimed is: 1. A method for up-regulating at least one gene involved in neuroprotection in the brain of a subject in need thereof, the method comprising: administering to said subject a composition comprising an effective amount of an extract from oil palm vegetation liquor, wherein said extract contains a mixture of phenolic compounds, fruit adds, fruit sugars and glycerol, wherein said extract contains an antioxidant content of about 1500 ppm gallic add equivalent; wherein the amount of the composition administered is sufficient to up-regulate at least one gene involved in neuroprotection, wherein the gene is selected from the group consisting of Arc, Cast, Gria 3 , Kcnb 1 , Kcnab 1 , Homer 1 , Dlgap 2 , Dlgh 4 , Sv 2 b , Stx 1 a , Gucylb 3 , Ncald, Bzrap 1 , Pelo, Ptprn, Ptprt, Fas, Egr 1 , and Egr 4 ; and wherein said composition is administered in the form of doses on a daily, weekly or monthly basis for a predetermined period of time, thereby providing neuroprotection in the brain of said subject. 2. The method of claim 1 , wherein the subject has at least one neurodegenerative disease or a disease related thereto. 3. The method of claim 1 , wherein the composition improves cognitive and motor functions in the subject. 4. The method of claim 1 , wherein the composition is administered in a dose dependent manner. 5. The method of claim 1 , wherein the composition is administered in a liquid dosage form. 6. The method of claim 1 , wherein the composition is administered in a pharmaceutically effective form. 7. The method of claim 1 , wherein the composition is administered in a nutraceutical form. 8. The method of claim 1 , wherein the composition is administered in a nutritional supplementary form. 9. The method of claim 1 , wherein the composition is administered in a suppository form. 10. The method of claim 1 , wherein the composition is administered in a form suitable for oral administration. 11. The method of claim 1 , wherein the composition is administered in a form suitable for intravenous administration. 12. A method of reducing inflammation in the brain of a patient having a neurodegenerative disease, the method comprising: administering to said patient a composition comprising an effective amount of an extract from oil palm vegetation liquor, wherein said extract contains a mixture of phenolic, compounds, fruit adds, fruit sugars and glycerol, wherein said extract contains an antioxidant content of about 1500 ppm gallic add equivalent; wherein at least one gene involved in acute phase response, aldehyde metabolism, hormone-mediated signaling, lipid metabolism, oxidoreductase activity, prostaglandin synthesis regulation, tumor necrosis factor-alpha/nuclear factor-kappaB (TNF-alpha/NF-kappaB) signaling, focal adhesion, and/or amino add metabolism is down-regulated; and wherein said composition is administered in the form of doses on a daily, weekly or monthly basis for a predetermined period of time, thereby reducing inflammation in the brain of the patient. 13. The method of claim 12 , wherein the composition improves cognitive and motor functions in the patient. 14. The method of claim 12 , wherein the composition is administered in a dose dependent manner. 15. The method of claim 12 , wherein the composition is administered in a liquid dosage form. 16. The method of claim 12 , wherein the composition is administered in a pharmaceutically effective form. 17. The method of claim 12 , wherein the composition is administered in a nutraceutical form. 18. A method for up-regulating tyrosine phosphatase and/or ionotropic glutamate receptor genes, and/or down-regulating at least one gene from the group consisting actin, Hoxa 5 , and Hoxb 5 in the brain of a subject suffering from Alzheimer's Disease, the method comprising: administering to said subject a composition comprising an effective amount of an extract from oil palm vegetation liquor, wherein said extract contains a mixture of phenolic compounds, fruit acids, fruit sugars and glycerol, wherein said extract contains an antioxidant content of about 1500 ppm gallic acid equivalent; and wherein said composition is administered in the form of doses on a daily, weekly or monthly basis for a predetermined period of time, thereby up-regulating tyrosine phosphatase and/or ionotropic glutamate receptor genes, and/or down-regulating at least one gene from the group consisting actin, Hoxa 5 , and Hoxb 5 in the brain of said subject.
Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title
for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia · CPC title
Anti-Parkinson drugs · CPC title
Drugs for disorders of the nervous system · CPC title
Plant extracts, their artificial duplicates or their derivatives · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.